Cargando…

Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis

Although anti-inflammatory and immunomodulatory measures have delayed the progression of ulcerative colitis (UC) to a certain extent, the adverse drug reactions and recurrence after recovery still trouble clinicians. Acupoint catgut embedding is a possible alternative strategy for the treatment of U...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yunfeng, Zhou, Manli, Tong, Yaling, Yin, Shuang, Hu, Gang, Jian, Weixiong, Zhu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704870/
https://www.ncbi.nlm.nih.gov/pubmed/36451450
http://dx.doi.org/10.1097/MD.0000000000030945
_version_ 1784840151414865920
author Yu, Yunfeng
Zhou, Manli
Tong, Yaling
Yin, Shuang
Hu, Gang
Jian, Weixiong
Zhu, Ying
author_facet Yu, Yunfeng
Zhou, Manli
Tong, Yaling
Yin, Shuang
Hu, Gang
Jian, Weixiong
Zhu, Ying
author_sort Yu, Yunfeng
collection PubMed
description Although anti-inflammatory and immunomodulatory measures have delayed the progression of ulcerative colitis (UC) to a certain extent, the adverse drug reactions and recurrence after recovery still trouble clinicians. Acupoint catgut embedding is a possible alternative strategy for the treatment of UC, but its clinical efficacy remains controversial. Therefore, this study systematically evaluated the clinical efficacy and safety of acupoint catgut embedding compared with conventional western medicine in the treatment of UC. METHODS: VIP, Wanfang, China National Knowledge Infrastructure, China Biology Medicine, PubMed, Embase, Web of Science, the Cochrane Library databases were searched. And the publication time of the literature was limited from the time that the database was established to February 2022. Two researchers independently screened the literature, extracted data, and assessed risk of bias as required. Meta-analysis was performed with Revman 5.3. Trial sequential analysis (TSA) was performed with TSA 0.9.5.10 Beta. Publication bias was assessed by Stata 15.0. And evidence quality was appraised with GRADEpro3.6. RESULTS: A total of 10 studies were listed, with a total sample size of 782 cases. Meta-analysis showed that compared with conventional western medicine, acupoint catgut embedding can effectively improve the total effective rate of clinical symptoms (relative risk [RR] = 1.16, 95% confidence interval [CI] = [1.09,1.24], P < .00001), endoscopic total effective rate (RR = 1.16, 95%CI = [1.08,1.25], P < .0001), clinical symptom cure rate (RR = 1.80, 95%CI = [1.37,2.38], P < .0001), and endoscopic cure rate (RR = 1.97, 95%CI = [1.36,2.86], P = .0004) of UC, but the adverse event rate (RR = 0.20, 95%CI = [0.01,4.00], P = .29) was similar. Trial sequential analysis indicated that the efficacy endpoint was conclusive. Harbord test confirmed no significant publication bias. The quality of evidence for these outcomes ranges from low to medium. CONCLUSION: The clinical efficacy of acupoint catgut embedding in the treatment of UC is superior to that of conventional western medicine, and the safety may be equivalent to that of conventional western medicine, which has the value of further research and exploration.
format Online
Article
Text
id pubmed-9704870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-97048702022-11-29 Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis Yu, Yunfeng Zhou, Manli Tong, Yaling Yin, Shuang Hu, Gang Jian, Weixiong Zhu, Ying Medicine (Baltimore) 4500 Although anti-inflammatory and immunomodulatory measures have delayed the progression of ulcerative colitis (UC) to a certain extent, the adverse drug reactions and recurrence after recovery still trouble clinicians. Acupoint catgut embedding is a possible alternative strategy for the treatment of UC, but its clinical efficacy remains controversial. Therefore, this study systematically evaluated the clinical efficacy and safety of acupoint catgut embedding compared with conventional western medicine in the treatment of UC. METHODS: VIP, Wanfang, China National Knowledge Infrastructure, China Biology Medicine, PubMed, Embase, Web of Science, the Cochrane Library databases were searched. And the publication time of the literature was limited from the time that the database was established to February 2022. Two researchers independently screened the literature, extracted data, and assessed risk of bias as required. Meta-analysis was performed with Revman 5.3. Trial sequential analysis (TSA) was performed with TSA 0.9.5.10 Beta. Publication bias was assessed by Stata 15.0. And evidence quality was appraised with GRADEpro3.6. RESULTS: A total of 10 studies were listed, with a total sample size of 782 cases. Meta-analysis showed that compared with conventional western medicine, acupoint catgut embedding can effectively improve the total effective rate of clinical symptoms (relative risk [RR] = 1.16, 95% confidence interval [CI] = [1.09,1.24], P < .00001), endoscopic total effective rate (RR = 1.16, 95%CI = [1.08,1.25], P < .0001), clinical symptom cure rate (RR = 1.80, 95%CI = [1.37,2.38], P < .0001), and endoscopic cure rate (RR = 1.97, 95%CI = [1.36,2.86], P = .0004) of UC, but the adverse event rate (RR = 0.20, 95%CI = [0.01,4.00], P = .29) was similar. Trial sequential analysis indicated that the efficacy endpoint was conclusive. Harbord test confirmed no significant publication bias. The quality of evidence for these outcomes ranges from low to medium. CONCLUSION: The clinical efficacy of acupoint catgut embedding in the treatment of UC is superior to that of conventional western medicine, and the safety may be equivalent to that of conventional western medicine, which has the value of further research and exploration. Lippincott Williams & Wilkins 2022-11-25 /pmc/articles/PMC9704870/ /pubmed/36451450 http://dx.doi.org/10.1097/MD.0000000000030945 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 4500
Yu, Yunfeng
Zhou, Manli
Tong, Yaling
Yin, Shuang
Hu, Gang
Jian, Weixiong
Zhu, Ying
Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title_full Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title_fullStr Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title_full_unstemmed Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title_short Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
title_sort meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: acupoint catgut embedding treating ulcerative colitis meta-analysis
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704870/
https://www.ncbi.nlm.nih.gov/pubmed/36451450
http://dx.doi.org/10.1097/MD.0000000000030945
work_keys_str_mv AT yuyunfeng metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT zhoumanli metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT tongyaling metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT yinshuang metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT hugang metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT jianweixiong metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis
AT zhuying metaanalysisandtrialsequentialanalysisofacupointcatgutembeddinginthetreatmentofulcerativecolitisacupointcatgutembeddingtreatingulcerativecolitismetaanalysis